Patient preferences for drug therapy in inflammatory arthritis: protocol for a living systematic review and evidence map to inform clinical practice guidelines

Pakeezah Saadat ,Nick Bansback, Marie Falahee, Mickaël Hiligsmann, Peter Tugwell, Rachelle Buchbinder, Samuel Whittle, Dawn P Richards, Laurie Proulx, Holger Schunemann, Pablo Alonso-Coello, Robby Nieuwlaat, Wojtek Wiercioch, Simon Kuper, Jordi Pardo Pardo, Glen Hazlewood

Patient preferences for drug therapy in inflammatory arthritis: protocol for a living systematic review and evidence map to inform clinical practice guidelines. BMJ Open 2025;15:e088267. doi:10.1136/ bmjopen-2024-088267

https://bmjopen.bmj.com/content/bmjopen/15/1/e088267.full.pdf

Previous
Previous

Describing randomization in trials included in systematic reviews in orthopaedic surgery

Next
Next

Impact of Clinical Information on Melanocytic Skin Lesion Pathology Diagnosis - A Scoping Review